A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 3, 2022

Primary Completion Date

January 3, 2025

Study Completion Date

January 3, 2025

Conditions
Kidney Disease, Chronic
Interventions
DRUG

BI 764198

BI 764198

DRUG

Placebo

Placebo matching BI 764198

Trial Locations (54)

2145

Westmead Hospital, Westmead

2170

Liverpool Hospital, Liverpool

3000

UZ Leuven, Leuven

3021

Sunshine Hospital, AT Albans

4029

Royal Brisbane and Women's Hospital, Herston

4125

Griffith Health, Southport

8011

New Zealand Clinical Research (ChristChurch), Christchurch

9016

Dunedin Hospital, Dunedin

10461

Jacobi Medical Center, The Bronx

19104

University of Pennsylvania, Philadelphia

27100

Fondazione Salvatore Maugeri, Pavia

27599

The University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

28041

Hospital Universitario 12 de Octubre, Madrid

30322

Emory Children's Center, Atlanta

30625

Medizinische Hochschule Hannover, Hanover

33076

HOP Pellegrin, Bordeaux

33126

Total Research Group, LLC, Miami

33308

Elixia Fort Lauderdale, LLC, Fort Lauderdale

33313

South Florida Research Institute, Lauderdale Lakes

35805

Nephrology Consultants, LLC, Huntsville

40138

Policlinico S. Orsola-Malpighi, Bologna

43210

The Ohio State University Wexner Medical Center, Columbus

44093

HOP Hôtel-Dieu, Nantes

44195

Cleveland Clinic, Cleveland

48109

University of Michigan Health System, Ann Arbor

50937

Universitätsklinikum Köln (AöR), Cologne

60523

NANI Research, LLC, Oak Brook

69120

Universitätsklinikum Heidelberg, Heidelberg

70124

A.O. Policlinico Giovanni XXIII di Bari, Bari

77054

Prolato Clinical Research Center-Houston-68087, Houston

79106

Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo

90502

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

91356

Valiance Clinical Research-Tarzana-68237, Tarzana

94121

University of California San Francisco, San Francisco

94270

HOP Bicêtre, Le Kremlin-Bicêtre

200051

Tongren hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200240

Shanghai Fifth People's Hospital affiliated to Fudan University, Shanghai

236000

Fu Yang people's Hospital, Fuyang

310014

Zhejiang Province People's Hospital, Hangzhou

330006

The First Affiliated Hospital of Nanchang University, Nanchang

510080

Guangdong Provincial People's Hospital, Guangzhou

The First Afiliated Hospital, Sun Yet-sen University, Guangzhou

530000

The First People's Hospital of Nanning, Nanning

90280-5219

Valiance Clinical Research-South Gate-67878, South Gate

75115-2011

Dallas Nephrology Associates Medical Clinic, DeSoto

08916

Hospital Germans Trias i Pujol, Badalona

08003

Hospital del Mar, Barcelona

08025

Fundació Puigvert, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

BD5 0NA

St Luke's Hospital, Bradford

CB2 0QQ

Addenbrooke's Hospital, Cambridge

M6 8HD

Salford Royal, Salford

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY